SEC Form 4 · accession 0001179110-15-012517
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John E Bishop
Officer — Senior VP, Pharmaceutical Scie
Period of report
Aug 20, 2015
Accepted (ET)
Aug 24, 2015 · 2:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 20, 2015 | S | 140 | $22.20 | D | 95,439 | D | |
| Common Stock | Aug 20, 2015 | S | 330 | $22.20 | D | 95,109 | D | |
| Common Stock | Aug 21, 2015 | S | 79 | $20.01 | D | 95,030 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2015.
- F2This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9 2009.